Hiroshi Shiku

Q: What Schools Are Affiliated With Hiroshi Shiku

Hiroshi Shiku is affiliated with the following schools: University of Shizuoka, University of Tokyo, Nagasaki University, Mie University, Osaka University, Kyoto University

Hiroshi Shiku's AcademicInfluence.com Rankings

Hiroshi Shiku

Engineering

#5114

World Rank

#6357

Historical Rank

Cybernetics

#83

World Rank

#89

Historical Rank

Biomedical Engineering

#362

World Rank

#371

Historical Rank

engineering Degrees

Download Badge

Engineering

Hiroshi Shiku's Degrees

PhD Biomedical Engineering University of Tokyo
Masters Biomedical Engineering Kyoto University
Bachelors Biomedical Engineering Kyoto University

Why Is Hiroshi Shiku Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hiroshi Shiku's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Eradication of established tumors by CD8+ T cell adoptive immunotherapy. (2000) (373)
Engineering hybrid exosomes by membrane fusion with liposomes (2016) (370)
Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. (1996) (362)
Classification of current anticancer immunotherapies (2014) (357)
De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. (2002) (300)
Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens (1976) (218)
Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera. (1979) (212)
RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses. (2008) (208)
Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma (1977) (207)
Expression of T-cell differentiation antigens on effector cells in cell- mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells (1975) (202)
Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR. (2009) (187)
Isolation of GD3 synthase gene by expression cloning of GM3 alpha-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody. (1994) (185)
Serological analysis of cell surface antigens of malignant human brain tumors. (1978) (184)
Notch signalling in hematopoiesis. (2003) (181)
CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses (2003) (178)
Ly antigens as markers for functionally distinct subpopulations of thymus-derived lymphocytes of the mouse (1975) (176)
Outcome of Disseminated Intravascular Coagulation in Relation to the Score when Treatment was Begun (1995) (169)
In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. (2006) (168)
Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts. (1997) (168)
Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer (2002) (167)
Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter. (1995) (167)
Cell surface antigens of human renal cancer defined by autologous typing (1979) (157)
Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura. (2007) (157)
Defining the critical hurdles in cancer immunotherapy (2011) (152)
Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis (ISTH) and of the Japanese Ministry of Health and Welfare for overt DIC (2003) (145)
Expression cloning of beta 1,4 N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides. (1992) (143)
mRNA expression of leukemia‐associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies (2004) (141)
Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF‐cleaving protease activity (2002) (138)
Tissue Factor Expression and Metastatic Potential of Colorectal Cancer (1998) (134)
Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells (2005) (134)
Human melanoma antigen AH is an autoantigenic ganglioside related to GD2 (1982) (132)
Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer (2015) (130)
Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals (2010) (128)
Reduced expression of nm23‐H1, but not of nm23‐H2, is concordant with the frequency of lymph‐node metastasis of human breast cancer (1993) (127)
Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel (2008) (123)
Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts. (2005) (123)
Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. (1993) (122)
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein. (2007) (122)
Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety. (2011) (121)
De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients (2008) (120)
CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I-alphabetaTCR interaction and become IL-10-producing active regulatory cells. (2008) (119)
[DNA vaccine]. (2008) (118)
Distinguishing Pancreatic Carcinoma From Other Periampullary Carcinomas by Analysis of Mutations in the Kirsten‐ras Oncogene (1991) (117)
Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics (1977) (116)
Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells (2018) (115)
Frequent Glycine‐to‐Aspartic Acid Mutations at Codon 12 of c‐Ki‐ras Gene in Human Pancreatic Cancer in Japanese (1990) (112)
Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS. (2017) (110)
Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma. (1997) (109)
Agonist-induced regulation of myosin phosphatase activity in human platelets through activation of Rho-kinase. (1999) (109)
A novel hydrophobized polysaccharide/oncoprotein complex vaccine induces in vitro and in vivo cellular and humoral immune responses against HER2-expressing murine sarcomas. (1998) (106)
Complex gangliosides are essential in spermatogenesis of mice: Possible roles in the transport of testosterone (1998) (105)
HER2-Specific T-Cell Immune Responses in Patients Vaccinated with Truncated HER2 Protein Complexed with Nanogels of Cholesteryl Pullulan (2006) (105)
Nanogel-based immunologically stealth vaccine targets macrophages in the medulla of lymph node and induces potent antitumor immunity. (2014) (105)
Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. (1996) (104)
IFN-γ Controls the Generation/Activation of CD4+CD25+ Regulatory T Cells in Antitumor Immune Response1 (2005) (98)
Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line. (1995) (97)
Presentation of a major histocompatibility complex class 1-binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide-truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy. (2002) (96)
Exosome‐mediated regulation of tumor immunology (2018) (90)
De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. (1998) (90)
Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients (2013) (87)
Activity of interleukin 6 in the differentiation of monocytes to macrophages and dendritic cells (2000) (85)
Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation. (2001) (85)
Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis. (1993) (84)
Increased plasma‐soluble fibrin monomer levels in patients with disseminated intravascular coagulation (1996) (82)
Expression of human nm23‐H1 and nm23‐H2 proteins in hepatocellular carcinoma (1994) (81)
De novo CD5‐positive diffuse large B‐cell lymphoma: clinical characteristics and therapeutic outcome (1999) (80)
Hematopoietic origin of hepatic stellate cells in the adult liver. (2008) (80)
Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling. (2008) (77)
Survival of human leukaemic B‐cell precursors is supported by stromal cells and cytokines: association with the expression of bcl‐2 protein (1999) (77)
Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance (2019) (75)
Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity (2001) (75)
Protein kinase C-catalyzed phosphorylation of an inhibitory phosphoprotein of myosin phosphatase is involved in human platelet secretion. (2001) (74)
Ly phenotype of cytotoxic T cells for syngeneic tumor (1976) (73)
Direct tumor recognition by a human CD4+ T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses (2015) (73)
Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents (1998) (73)
Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases (2000) (72)
Expression of nm23‐Hl and nm23‐H2 Proteins in Prostate Carcinoma (1993) (70)
A novel role for Notch ligand Delta‐1 as a regulator of human Langerhans cell development from blood monocytes (2005) (70)
A new function of Nm23/NDP kinase as a differentiation inhibitory factor, which does not require it's kinase activity (1995) (70)
Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma. (1991) (69)
Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries (1998) (67)
Heterogeneity in the Expression Pattern of Two Ganglioside Synthase Genes During Mouse Brain Development (1996) (65)
Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas. (2003) (65)
Antibody response against NY‐ESO‐1 in CHP‐NY‐ESO‐1 vaccinated patients (2007) (65)
Genomic organization and chromosomal assignment of the human beta1, 4-N-acetylgalactosaminyltransferase gene. Identification of multiple transcription units. (1996) (64)
Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation (1996) (64)
Molecular cloning and functional expression of the second mouse nm23/NDP kinase gene, nm23‐M2 (1992) (64)
Inhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhibitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivo. (1997) (64)
Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML (2003) (63)
The effects of the site-directed removal of N-glycosylation sites from beta-1,4-N-acetylgalactosaminyltransferase on its function. (1995) (62)
Importance of CD80/CD86–CD28 interactions in the recognition of target cells by CD8+CD122+ regulatory T cells (2008) (62)
siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions (2011) (62)
Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity. (1979) (62)
Roles of CD4+ and CD8+ cells, and the effect of administration of recombinant murine interferon gamma in listerial infection (1990) (62)
Regulation of myosin phosphatase through phosphorylation of the myosin-binding subunit in platelet activation. (1997) (61)
Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination. (2018) (61)
Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment (1998) (60)
Hemostatic molecular markers before the onset of disseminated intravascular coagulation (1999) (59)
Increased tissue factor pathway inhibitor in patients with acute myocardial infarction (1997) (59)
Alloantigen-induced T-cell proliferation: Lyt phenotype of responding cells and blocking of proliferation by Lyt antisera. (1980) (59)
GD2 ganglioside on human T-lymphotropic virus type I-infected T cells: possible activation of beta-1,4-N-acetylgalactosaminyltransferase gene by p40tax. (1993) (57)
Treatment outcome of nasal NK‑cell lymphoma: A report of 12 consecutively‑diagnosed cases and a review of the literature (2001) (57)
Expression profiling analysis of the CD5+ diffuse large B‐cell lymphoma subgroup: Development of a CD5 signature (2006) (57)
Expression of CD44 Variant Exons 8–10 in Colorectal Cancer and Its Relationship to Metastasis (1995) (56)
Reprogramming of human postmitotic neutrophils into macrophages by growth factors. (2004) (56)
High plasma fibrinogen level is associated with poor clinical outcome in DIC patients (2003) (56)
Gene expression profiling of peripheral T-cell lymphoma including gammadelta T-cell lymphoma. (2009) (54)
Expression of nm23/NDP kinase proteins on the cell surface. (1993) (54)
Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 allele. (2012) (53)
Expression of DCC Protein in Colorectal Tumors and Its Relationship to Tumor Progression and Metastasis (1999) (53)
Genetic and enzymatic basis for the differential expression of GM2 and GD2 gangliosides in human cancer cell lines. (1993) (53)
Increased platelet aggregability in response to shear stress in acute myocardial infarction and its inhibition by combined therapy with aspirin and cilostazol after coronary intervention. (2000) (53)
Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers. (1988) (53)
Cell‐mediated cytotoxicity for cultured autologous melanoma cells (1979) (53)
Attenuation of Interleukin 2 Signal in the Spleen Cells of Complex Ganglioside-lacking Mice* (1999) (51)
Bax Induction Activates Apoptotic Cascade via Mitochondrial Cytochrome c Release and Bax Overexpression Enhances Apoptosis Induced by Chemotherapeutic Agents in DLD‐1 Colon Cancer Cells (2000) (50)
IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response. (2005) (50)
Gemcitabine enhances Wilms’ tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response (2011) (50)
Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers. (1990) (50)
Features of early gastric cancer and gastric adenoma by enhanced-magnification endoscopy (2006) (49)
CD8+CD122+CD49dlow regulatory T cells maintain T-cell homeostasis by killing activated T cells via Fas/FasL-mediated cytotoxicity (2016) (49)
Importance of CD4+ Helper T-cells in Antitumor Immunity (2003) (48)
Substrate Specificity of 1,4-N-Acetylgalactosaminyltransferase in Vitro and in cDNA-transfected Cells (1995) (48)
Activated t‐lymphocytes with polyclonal gammopathy in patients with human t‐lymphotropic virus type i—associated myelopathy (1988) (48)
Determination of Cellularly Processed HLA-A2402-Restricted Novel CTL Epitopes Derived from Two Cancer Germ Line Genes, MAGE-A4 and SAGE (2005) (48)
Analysis of peripheral and local anti‐tumor immune response in esophageal cancer patients after NY‐ESO‐1 protein vaccination (2008) (48)
Glucocorticoid‐induced tumor necrosis factor receptor stimulation enhances the multifunctionality of adoptively transferred tumor antigen‐specific CD8+ T cells with tumor regression (2009) (48)
Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia (2002) (48)
High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine. (2014) (47)
Expression of tissue factor is associated with clinical features and angiogenesis in prostate cancer. (2002) (47)
Decreased Plasma Tissue Factor Pathway Inhibitor Levels in Patients with Thrombotic Thrombocytopenic Purpura (1995) (47)
Tissue factor expression in endothelial cells in health and disease (1995) (47)
Reduced expression of deleted colorectal carcinoma (DCC) protein in established colon cancers. (1998) (47)
Detection of the c‐myc Gene Product in Urinary Bladder Cancer (1990) (46)
Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology (2009) (46)
Successful autologous peripheral blood stem cell transplantation for relapsed intravascular lymphomatosis (2001) (46)
Activation of p21WAF1/Cip1 expression by a temperature-sensitive mutant of human p53 does not lead to apoptosis. (1995) (46)
Point Mutations of c‐ras Genes in Human Bladder Cancer and Kidney Cancer (1990) (46)
Exosomal regulation of lymphocyte homing to the gut. (2018) (46)
Tumor progression inhibits the induction of multifunctionality in adoptively transferred tumor‐specific CD8+ T cells (2009) (45)
Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-beta. (1996) (45)
Development of a cancer vaccine: peptides, proteins, and DNA (2000) (45)
Intracellular tumor-associated antigens represent effective targets for passive immunotherapy. (2012) (45)
Expression of α2,8-sialyltransferase (GD3 synthase) gene in human cancer cell lines: high level expression in melanomas and up-regulation in activated T lymphocytes (1995) (45)
Frequency of Abnormal Biphasic aPTT Clot Waveforms in Patients with Underlying Disorders Associated with Disseminated Intravascular Coagulation (2006) (45)
Interleukin-17 Induces an Atypical M2-Like Macrophage Subpopulation That Regulates Intestinal Inflammation (2014) (44)
Characterization of the isoenzymes of cyclic nucleotide phosphodiesterase in human platelets and the effects of E4021. (1996) (44)
Peptide Vaccine Induces Enhanced Tumor Growth Associated with Apoptosis Induction in CD8+ T Cells (2010) (44)
Production and characterization of monoclonal antibody against 10S DNA polymerase a from calf thymus (1982) (43)
Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432. (2009) (43)
In vitro Stimulation of CD8 and CD4 T Cells by Dendritic Cells Loaded with a Complex of Cholesterol-Bearing Hydrophobized Pullulan and NY-ESO-1 Protein: Identification of a New HLA-DR15–Binding CD4 T-Cell Epitope (2006) (43)
The Soluble Notch Ligand, Jagged-1, Inhibits Proliferation of CD34+ Macrophage Progenitors (2002) (43)
A novel human HER2‐derived peptide homologous to the mouse Kd‐restricted tumor rejection antigen can induce HLA‐A24‐restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals (2000) (41)
A HER2/NEU‐derived peptide, a Kd‐restricted murine tumor rejection antigen, induces HER2‐specific HLA‐A2402‐restricted CD8+ cytotoxic T lymphocytes (2000) (41)
Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia. (2013) (41)
Semiquantitative analysis of integrated genomes of human T-lymphotropic virus type I in asymptomatic virus carriers. (1991) (41)
Relationship between the anti‐HTLV‐1 antibody level, the number of abnormal lymphocytes and the viral‐genome dose in HTLV‐1‐infected individuals (1993) (40)
IFN-gamma-dependent type 1 immunity is crucial for immunosurveillance against squamous cell carcinoma in a novel mouse carcinogenesis model. (2009) (40)
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient (2008) (40)
erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection. (1994) (40)
Differential Regulatory Function of Resting and Preactivated Allergen-Specific CD4+CD25+ Regulatory T Cells in Th2-Type Airway Inflammation1 (2008) (40)
Co-Introduced Functional CCR2 Potentiates In Vivo Anti-Lung Cancer Functionality Mediated by T Cells Double Gene-Modified to Express WT1-Specific T-Cell Receptor (2013) (39)
Correlation of c-myc expression with nuclear pleomorphism in human renal cell carcinoma. (1989) (39)
Alternatively spliced mRNA of the pX region of human T lymphotropic virus type I proviral genome (1991) (38)
Complex gangliosides are essential in spermatogenesis of mice: possible roles in the transport of testosterone. (1999) (38)
Differences in sensitivity to induction of apoptosis among rat fibroblast cells transformed by HTLV-I tax gene or cellular nuclear oncogenes. (1995) (38)
Expression of c-myc gene product in gastric carcinoma. (1991) (38)
Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome (2016) (38)
Inhibitory action of nm23 proteins on induction of erythroid differentiation of human leukemia cells. (1995) (37)
The Blood Group P1 Synthase Gene Is Identical to the Gb3/CD77 Synthase Gene (2003) (36)
Expression of c‐myc Oncogens Product and ras Family Oncogene Products in Various Human Malignant Lymphomas Defined by Immunohistochemical Techniques (1988) (36)
Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation (1996) (35)
Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation (1997) (35)
Expression of CD44 Variant Exons 8‐10 in Gastric Cancer (1995) (34)
Rapid αβ TCR-mediated responses in γδ T cells transduced with cancer-specific TCR genes (2009) (34)
gamma delta T-cell lymphoma: a clinicopathologic study of 6 cases including extrahepatosplenic type. (1999) (34)
Plasma Levels of Total Plasminogen Activator Inhibitor-I (PAI-I) and tPA/PAI-1 Complex in Patients With Disseminated Intravascular Coagulation and Thrombotic Thrombocytopenic Purpura (2001) (34)
Acute myeloid leukemia with t(8;21)(q22;q22) manifesting as granulocytic sarcomas in the rhinopharynx and external acoustic meatus at relapse after high-dose cytarabine: case report and review of the literature. (2004) (34)
Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor α-chain predicts a poor prognosis (2007) (34)
Hemostatic abnormalities in patients with pulmonary embolism compared with that in deep vein thrombosis (1995) (33)
Biphasic expression of CD4 in acute myelocytic leukemia (AML) cells: AML of monocyte origin and hematopoietic precursor cell origin (1998) (33)
CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection (1991) (33)
IL-2-dependent ATL cell lines with phenotypes differing from the original leukemia cells. (1991) (33)
Induction of regulatory T cell-resistant helper CD4+ T cells by bacterial vector. (2008) (33)
Hemostatic abnormalities and increased vascular endothelial cell markers in patients with red cell fragmentation syndrome induced by mitomycin C (1995) (32)
Expression cloning of beta 1,4 N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides. (1992) (32)
Thioredoxin suppresses airway inflammation independently of systemic Th1/Th2 immune modulation (2010) (31)
Intratumoral Injection of Propionibacterium acnes Suppresses Malignant Melanoma by Enhancing Th1 Immune Responses (2011) (31)
A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression (2012) (30)
Haemostatic abnormalities and thrombotic disorders in malignant lymphoma (2004) (30)
Cyclin D1 Expression Is Useful as a Prognostic Indicator for Advanced Esophageal Carcinomas, but Not for Superficial Tumors (2000) (30)
Increased Soluble Fibrin in Plasma of Patients with Disseminated Intravascular Coagulation (2003) (30)
Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease (1999) (30)
Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients. (1998) (30)
Post-immune UV irradiation induces Tr1-like regulatory T cells that suppress humoral immune responses. (2008) (29)
Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. (2006) (29)
Gene-Modified Human α/β-T Cells Expressing a Chimeric CD16-CD3ζ Receptor as Adoptively Transferable Effector Cells for Anticancer Monoclonal Antibody Therapy (2014) (29)
Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms. (1996) (29)
Alteration of nm23 gene expression during the induced differentiation of human leukemia cell lines. (1994) (29)
Expression of ras p21 in mammary and extramammary Paget's disease. (1990) (29)
Bax overexpression enhances cytochrome c release from mitochondria and sensitizes KATOIII gastric cancer cells to chemotherapeutic agent-induced apoptosis. (2000) (29)
Serological response of melanoma patients receiving melanoma cell vaccines. I. Autologous cultured melanoma cells (1982) (29)
Immunohistochemical expression and clinicopathological assessment of the cancer testis antigens NY-ESO-1 and MAGE-A4 in high-grade soft-tissue sarcoma. (2019) (28)
THE ROLE OF CD8+ AND CD4+ CELLS IN ISLET ALLOGRAFT REJECTION (1990) (28)
Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation (1998) (28)
Increased Plasma Thrombomodulin as a Vascular Endothelial Cell Marker in Patients With Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome (2001) (28)
Translocation of protein phosphatase 1 catalytic subunits during 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL-60 cells. (1995) (28)
Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction (1995) (28)
Contrast-enhanced ultrasound examination of lymph nodes in different types of lymphoma. (2006) (27)
Preferential reduction of nm23-H1 gene product in metastatic tissues from papillary and follicular carcinomas of the thyroid. (1995) (27)
Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers. (2000) (27)
Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice. (1993) (27)
Pleiotropic role of histone deacetylases in the regulation of human adult erythropoiesis (2006) (26)
Efficient ex vivo generation of dendritic cells from CD14+ blood monocytes in the presence of human serum albumin for use in clinical vaccine trials (2001) (26)
Plasma levels of activated protein C–protein C inhibitor complex in patients with hypercoagulable states (2000) (26)
Aurora kinase A-specific T-cell receptor gene transfer redirects T lymphocytes to display effective antileukemia reactivity. (2012) (26)
Granulocytic sarcoma of mesentery in acute myeloid leukemia with CBFB/MYH11 fusion gene but not inv(16) chromosome: case report and review of literature. (2006) (26)
Gene expression profiling of diffuse large B-Cell lymphomas supervised by CD5 expression (2015) (26)
Differential Association of Protein Ser/Thr Phosphatase Types 1 and 2A with the Cytoskeleton upon Platelet Activation (1996) (26)
Activities of granulocyte‐macrophage colony‐stimulating factor and interleukin‐3 on monocytes (2004) (26)
Established IL‐2‐dependent double‐negative (CD4‐ CD8‐) TCRαβ/CD3+ ATL cells: induction of CD4 expression (1994) (26)
Phase I Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with Advanced Cancer. (2014) (26)
T‐cell receptor gene therapy targeting melanoma‐associated antigen‐A4 inhibits human tumor growth in non‐obese diabetic/SCID/γcnull mice (2012) (25)
Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignancies. (2005) (25)
Regression of primary lymphoma of the ampulla of Vater after eradication of Helicobacter pylori. (2001) (25)
Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients. (1994) (25)
Involvement of T‐cell subsets and natural killer (NK) cells in the growth suppression of murine fibrosarcoma cells transfected with interleukin‐12 (IL‐12) genes (1997) (25)
Tissue factor messenger RNA levels in leukocytes compared with tissue factor antigens in plasma from patients in hypercoagulable state caused by various diseases (2004) (24)
HER2 peptide-specific CD8+ T cells are proportionally detectable long after multiple DNA vaccinations (2002) (24)
Histopathological Study of the Role of CD4- and CD8-Positive T Cells on Bone Resorption Induced by Escherichia coli Endotoxin (1998) (24)
Possible involvement of bcl‐2 in regulation of cell‐cycle progression of haemopoietic cells by transforming growth factor‐β1 (1999) (24)
Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation (1999) (24)
Molecular and phenotypic analysis of Philadelphia chromosome-positive bilineage leukemia: possibility of a lineage switch from T-lymphoid leukemic progenitor to myeloid cells. (2006) (24)
The Membrane Proteinase 3 Expression on Neutrophils Was Downregulated After Treatment With Infliximab in Patients With Rheumatoid Arthritis (2008) (23)
Hemostatic Abnormalities in Patients With Thrombotic Complications on Maintenance Hemodialysis (2000) (23)
Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells (2019) (23)
Aberrations of the Tissue Factor Pathway in Patients Positive for Lupus Anticoagulant (1999) (23)
Elevated levels of leukocyte tissue factor mRNA in patients with venous thromboembolism. (2005) (23)
Electrochemical/photochemical formation of enzyme patterns on glass substrates using a scanning electrochemical/confocal microscope (2003) (23)
Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC. (2001) (23)
Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype. (2000) (23)
Cytotoxic reactions of murine lymphoid cells studied with a tritiated proline microcytotoxicity test. (1975) (23)
Isolation of human nm23 genomes and analysis of loss of heterozygosity in primary colorectal carcinomas using a specific genomic probe. (1994) (23)
Expression of alpha 2,8-sialyltransferase (GD3 synthase) gene in human cancer cell lines: high level expression in melanomas and up-regulation in activated T lymphocytes. (1995) (23)
PRAD1/Cyclin D1 gene overexpression in mantle cell lymphoma. (1996) (22)
The Roles of CD8+ and CD4+ Cells in Tumor Rejection (1989) (22)
Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha). (2003) (22)
Usefulness of Fully Automated Measurement of Reticulated Platelets Using Whole Blood (2005) (21)
Time-dependent transition of the immunoglobulin G subclass and immunoglobulin E response in cancer patients vaccinated with cholesteryl pullulan-melanoma antigen gene-A4 nanogel (2016) (21)
Adult T cell leukaemia cells are of CD4+ CDw29+ T cell origin and secrete a B cell differentiation factor (1989) (21)
First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer (2019) (21)
UV irradiation of immunized mice induces type 1 regulatory T cells that suppress tumor antigen specific cytotoxic T lymphocyte responses (2011) (21)
Highly increased plasma concentrations of the nicked form of beta(2) glycoprotein I in patients with leukemia and with lupus anticoagulant: measurement with a monoclonal antibody specific for a nicked form of domain V. (2000) (21)
A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy. (2013) (21)
De novo CD5-positive diffuse large B-cell lymphoma of the temporal bone presenting with an external auditory canal tumor. (2006) (20)
Usefulness of Measurement of Reticulated Platelets for Diagnosis of Idiopathic Thrombocytopenic Purpura (2005) (20)
Differential involvement of CD4+ cells in mediating skin graft rejection against different amounts of transgenic H-2K(b) antigen (1991) (20)
Analysis of cell surface molecules on human platelets with monoclonal antibodies. I. Identification of four platelet-specific surface molecules. (1986) (20)
MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours (2020) (20)
Long-term phenotypic, functional and genetic stability of cancer-specific T-cell receptor (TCR) αβ genes transduced to CD8+ T cells (2008) (20)
Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases (2003) (19)
Ileocolonic lymphomas: a series of 16 cases. (2005) (19)
Hemostatic Abnormalities and Changes Following Bone Marrow Transplantation (2004) (19)
Granulocyte colony‐stimulating factor and its receptor in acute promyelocytic leukemia (1998) (19)
Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with deep vein thrombosis. (2005) (18)
T cell receptor‐mediated stimulation of mouse thymocytes induces up‐regulation of the GM2/GD2 synthase gene (1995) (18)
Myeloid differentiation antigen and cytokine receptor expression on acute myelocytic leukaemia cells with t(16;21)(p11;q22): frequent expression of CD56 and interleukin‐2 receptor α chain (1999) (18)
Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia (2016) (18)
Long-term survival of orthotopic Lewis liver grafts in Wistar Furth rats. Elimination or inactivation of effector CTL and altered antigenicity as possible reasons for tolerance. (1994) (18)
Human Cancer Immunology (1980) (18)
Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitus. (1997) (18)
First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors (2020) (18)
Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease. (2001) (18)
Additional t(11;17)(q23;q21) in a patient with Philadelphia-positive mixed lineage antigen-expressing leukemia. (2001) (18)
Guanine-Rich Sequences Are a Dominant Feature of Exosomal microRNAs across the Mammalian Species and Cell Types (2016) (17)
Expressions of four major protein Ser/Thr phosphatases in human primary leukemic cells (1999) (17)
Elevated Plasma Levels of Fibrin Degradation Productsby Granulocyte-Derived Elastase in Patients with Disseminated Intravascular Coagulation (2005) (17)
Low BCL-2 expression in acute leukemia with t(8;21) chromosomal abnormality (1999) (17)
Kobayashi T, Ruan SB, Clodi K, Kliche KO, Shiku H, Andreeff M and Zhang WOverexpression of bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents. Oncogene 16: 1587-1591 (1998) (17)
State-of-the-Art Review : Increased Activated Protein C: Protein C Inhibitor Complex and Decreased Protein C Inhibitor Levels in Patients with Chronic Renal Failure on Maintenance Hemodialysis (1999) (17)
Independent and differential expression of two isotypes of human Nm23: analysis of the promoter regions of the nm23-H1 and H2 genes. (1996) (17)
Plasma concentration of itraconazole and its antifungal prophylactic efficacy in patients with neutropenia after chemotherapy for acute leukemia (1999) (16)
Relationship between development of nephrotoxicity and blood concentration of cyclosporine A in bone-marrow transplanted recipients who received the continuous intravenous infusion. (2003) (16)
UV irradiation after immunization induces type 1 regulatory T cells that suppress Th2-type immune responses via secretion of IL-10. (2010) (16)
Decreased ADAMTS13 activity in plasma from patients with thrombotic thrombocytopenic purpura. (2007) (16)
Substrate specificity of beta 1,4-N-acetylgalactosaminyltransferase in vitro and in cDNA-transfected cells. GM2/GD2 synthase efficiently generates asialo-GM2 in certain cells. (1995) (16)
Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients (2021) (16)
Anti-idiotypic antibodies against UV-induced tumor-specific CTL clones. Preparation in syngeneic combination. (1988) (16)
Cytogenetic and cellular characteristics of a human embryonal rhabdomyosarcoma cell line, RMS-YM. (1991) (16)
Case of chronic‐phase chronic myelogenous leukemia with an abdominal hematopoietic tumor of leukemic clone origin (2004) (16)
Generation of peptide-specific CD8+ T cells by phytohemagglutinin-stimulated antigen-mRNA-transduced CD4+ T cells. (2006) (15)
Bone marrow-derived dendritic cells incorporate and process hydrophobized polysaccharide/oncoprotein complex as antigen presenting cells. (1999) (15)
Detection of the CBFB/MYH11 fusion gene in de novo acute myeloid leukemia (AML): a single-institution study of 224 Japanese AML patients. (2007) (15)
HUB1 is an autoantigen frequently eliciting humoral immune response in patients with adult T cell leukemia. (1999) (15)
Induction of in vitro and in vivo anti‐tumor responses by sensitization of mice with liposomes containing a crude butanol extract of leukemia cells and transferred inter‐membranously with cell‐surface proteins (1991) (15)
CD21S antigen expression in tumour cells of diffuse large B‐cell lymphomas is an independent prognostic factor indicating better overall survival (2004) (15)
Notch ligand Delta‐1 differentially modulates the effects of gp130 activation on interleukin‐6 receptor α‐positive and ‐negative human hematopoietic progenitors (2007) (15)
PROTEINASE 3 EXPRESSION ON NEUTROPHIL MEMBRANES FROM PATIENTS WITH INFECTIOUS DISEASE (2006) (15)
Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group. (1996) (15)
Genetic remodeling of gangliosides resulted in the enhanced reactions to the foreign substances in skin. (1997) (15)
1 alpha,25-dihydroxyvitamin D3-induced upregulation of calcineurin during leukemic HL-60 cell differentiation. (1996) (15)
Reduced Cd 4 + Cd 25 + T cells in patients with idiopathic thrombocytopenic purpura (2006) (14)
Up‐regulation of protein serine/threonine phosphatase type 2C during 1α,25‐dihydroxyvitamin D3‐induced monocytic differentiation of leukemic HL‐60 cells (1995) (14)
Antileukemia multifunctionality of CD4+ T cells genetically engineered by HLA class I-restricted and WT1-specific T-cell receptor gene transfer (2015) (14)
Genomic Organization and Chromosomal Assignment of the Human β1,4-N-Acetylgalactosaminyltransferase Gene (1996) (14)
CD4+ T cells support polyfunctionality of cytotoxic CD8+ T cells with memory potential in immunological control of tumor (2020) (14)
Expression of hepatocyte growth factor(hgf) and C-met gene in human gastric-cancer cell-lines. (1993) (14)
Decreased tissue factor and tissue‐plasminogen activator antigen in relapsed acute promyelocytic leukemia (2000) (14)
Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation (1999) (14)
IL-3 can not replace GM-CSF in inducing human monocytes to differentiate into Langerhans cells. (2007) (14)
Analysis of ras gene expression in stomach cancer by anti-ras p21 monoclonal antibodies. (1988) (14)
Human nm23-h1-protein and h2-protein have similar nucleoside diphosphate kinase-activities. (1992) (14)
Tumor-specific Crosslinking of GITR as Costimulation for Immunotherapy (2010) (14)
Antibody-dependent cell-mediated cytotoxicity for cultured autologous melanoma cells. (1981) (13)
Distinguishing functional exosomes and other extracellular vesicles as a nucleic acid cargo by the anion‐exchange method (2022) (13)
Human bone marrow stromal cells simultaneously support B and T/NK lineage development from human haematopoietic progenitors: a principal role for flt3 ligand in lymphopoiesis (2012) (13)
Increased thrombopoietin levels in idiopathic thrombocytopenic purpura patients with a poor response to steroid therapy. (1998) (13)
Assessment of Surface Glycan Diversity on Extracellular Vesicles by Lectin Microarray and Glycoengineering Strategies for Drug Delivery Applications. (2021) (13)
Rho-kinase induces association of adducin with the cytoskeleton in platelet activation. (2005) (13)
Participation of a dominant cytotoxic T cell population defined by a monoclonal antibody in syngeneic anti‐tumor responses (1990) (13)
Gastric mucosa-associated lymphoid tissue lymphoma with a focal high-grade component diagnosed by EUS and endoscopic mucosal resection for histologic evaluation. (2000) (13)
A putative role for histone deacetylase in the differentiation of human erythroid cells. (2005) (12)
Development of a unique T-cell receptor gene-transferred Tax-redirected T-cell immunotherapy for adult T-cell leukemia. (2020) (12)
Epirubicin, Identified Using a Novel Luciferase Reporter Assay for Foxp3 Inhibitors, Inhibits Regulatory T Cell Activity (2016) (12)
Successful treatment with low‐dose splenic irradiation for massive splenomegaly in an elderly patient with hairy‐cell leukemia (2001) (12)
Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation. (2003) (12)
Overcoming regulatory T‐cell suppression by a lyophilized preparation of Streptococcus pyogenes (2013) (12)
Expression of Kirsten‐ras p21 in Gastric Cancer Correlates with Tumor Progression and Is Prognostic (1994) (12)
Epoc-1: a POU-domain gene expressed in murine epidermal basal cells and thymic stromal cells. (1993) (12)
Mapping peroxidase in plant tissues by scanning electrochemical microscopy. (2001) (12)
Treatment of radiation-induced hemorrhagic duodenitis with argon plasma coagulation. (2004) (12)
State-of-the-Art Review : Elevated Tissue Factor Levels in Leukemic Cell Homogenate (2000) (12)
Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens (1986) (12)
Low p53 expression of acute myelocytic leukemia cells with t(8;21) chromosome abnormality: association with low p14(ARF) expression. (2006) (12)
Development of Mixed-Type Autoimmune Hemolytic Anemia and Evans’ Syndrome following Chicken Pox Infection in a Case of Low-Titer Cold Agglutinin Disease (2006) (12)
Rat cytotoxic T lymphocytes against human T-lymphotropic virus type 1-infected cells recognize gag gene and env gene encoded antigens. (1989) (11)
Preferential usage of JH2 in D‐J joinings with DQ52 is determined by the primary DNA sequence and is largely dependent on recombination signal sequences (1992) (11)
Comparison of multiple rosetting assays for detecting antibody reactivity of different immunoglobulin classes against surface antigens of benign and malignant tissue culture cells. (1980) (11)
Acute promyelocytic leukemia with del(6)(p23). (2000) (11)
Clinical relevance of antigen spreading pattern induced by CHP-MAGE-A4 cancer vaccination. (2016) (11)
Correlation of p53 expression and proliferative activity in gastric cancer. (1993) (11)
Analysis of cell surface molecules on human platelets with monoclonal antibodies. II. Diversity of antibody-binding sites on molecules and its relation to platelet function. (1986) (11)
Increased Expression of ras Genes in Non‐Hodgkin's Lymphomas Is not Associated with Oncogenic Activation of Those Genes by Point Mutation (1989) (11)
A new differentiation antigen defining a subpopulation of mouse T cells (1976) (11)
K‐ras gene mutations in intrahepatic bile duct tumors of Syrian golden hamsters (1997) (11)
Decreased expression of protein phosphatase type 2A in HL-60 variant (HL-60RAr) cells resistant to induction of cell differentiation by all-trans retinoic acid. (1995) (11)
Thrombomodulin accelerates activated protein C production and inhibits thrombin generation in the plasma of disseminated intravascular coagulation patients (2005) (10)
NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma (2018) (10)
Hemostatic markers in Japanese patients undergoing anticoagulant therapy under thrombo-test monitoring. (1999) (10)
Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model. (2013) (10)
Plasma levels of activated FVII in various diseases. (1996) (10)
Systemic CD8+ T Cell-Mediated Tumoricidal Effects by Intratumoral Treatment of Oncolytic Herpes Simplex Virus with the Agonistic Monoclonal Antibody for Murine Glucocorticoid-Induced Tumor Necrosis Factor Receptor (2014) (10)
Clinicopathologic Significance of Loss of CD19 Expression in Diffuse Large B-Cell Lymphoma (2007) (10)
Diverse Expression of β1,4‐N‐Acetylgalactosaminyltransferase Gene in the Adult Mouse Brain (1995) (10)
Bax-induction alone is sufficient to activate apoptosis cascade in wild-type Bax-bearing K562 cells, and the initiation of apoptosis requires simultaneous caspase activation. (2002) (10)
Analysis of Clonal Relationship Using Single-Cell Polymerase Chain Reaction in a Patient with Concomitant Mantle Cell Lymphoma and Multiple Myeloma (2001) (10)
Acute interstitial pneumonitis during chemotherapy for haematological malignancy. (2005) (9)
Two Independent Clones in Myelodysplastic Syndrome Following Treatment of Acute Myeloid Leukemia (2002) (9)
CD44 with variant exons 8-10 in colorectal tumors. (1996) (9)
Alteration of tumor phenotypes of B16 melanoma after genetic remodeling of the ganglioside profile. (2000) (9)
Hemostatic abnormalities and leukocyte activation caused by infection in patients with malignant lymphoma during chemotherapy. (2006) (9)
Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with disseminated intravascular coagulation. (2005) (9)
Gene expression profiling of diffuse large B‐cell lymphoma supervised by CD21 expression (2008) (9)
Good or Poor Responses of Hemostatic Molecular Markers in Patients with Hematopoietic Disorders After Treatment of Disseminated Intravascular Coagulation (2003) (9)
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome (2022) (9)
Inhibition by Rho-kinase and protein kinase C of myosin phosphatase is involved in thrombin-induced shape change of megakaryocytic leukemia cell line UT-7/TPO. (2005) (9)
V(D)J recombinase activity in primary and secondary murine lymphoid organs: assessment by a PCR assay with extrachromosomal plasmids. (1991) (9)
Differential cell division history between neutrophils and macrophages in their development from granulocyte–macrophage progenitors (2006) (9)
Diversity of Cellular Molecules in Human Cells Detected by Monoclonal Antibodies Reactive with c‐myc Proteins Produced in Escherichia coli (1989) (9)
Preclinical safety pharmacology study of a novel protein-based cancer vaccine CHP-NY-ESO-1. (2008) (9)
Effects of atorvastatin on serum lipids, lipoproteins, and hemostasis (2005) (9)
Effector cells of lethal graft-versus-host disease (GVHD) in nude mice. (1989) (9)
The role of CD8+ and CD4+ cells in rejection of multiple minor H-disparate skin grafts. (1989) (9)
Possible involvement of calcineurin in retinoic acid-induced inhibition of leukemic HL-60 cell proliferation. (1998) (9)
State-of-the-Art Review : Outcome of Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome in Japan (1999) (9)
Essential roles of tumor-derived helper T cell epitopes for an effective peptide-based tumor vaccine. (2003) (8)
Upregulated production of IL-6, but not IL-10, by interferon-alpha induces SOCS3 expression and attenuates STAT1 phosphorylation in myeloma cells. (2004) (8)
Adoptive Transfer of WT1-Specific TCR Gene-Transduced Lymphocytes in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia (2015) (8)
Production and characterization of monoclonal antibodies against the polyamine, spermine: immunocytochemical localization in rat tissues (1994) (8)
Site restricted and neuron dominant expression of α2,8sialyltansferase gene in the adult mouse brain and retina (1996) (8)
Mouse. I. Murine leukemia virus-related antigens and allo- antigens on cultured fibroblasts and sarcoma cells. Description of a unique antigen on balb/c meth a sarcoma. (1977) (8)
Heterogeneous copy numbers of API2-MALT1 chimeric transcripts in mucosa-associated lymphoid tissue lymphoma (2003) (8)
Plasma Levels of Heparin Cofactor II (HCII) and Thrombin-HCII Complex in Patients with Disseminated Intravascular Coagulation (2002) (8)
Role for C-MPL and its ligand thrombopoietin in early hematopoiesis. (1997) (8)
Retroviruses prepared from human DAF expressing murine packaging cells acquire resistance against human serum. (1999) (8)
Bcl-2 in Cell-Cycle Regulation of Hematopoietic Cells by Transforming Growth Factor-β1 (2000) (8)
Phase I and preliminary phase II studies on aclacinomycin A in patients with acute leukemia (1980) (8)
Limited expression of cancer-testis antigens in renal cell carcinoma patients. (2013) (8)
Fluorescent In Situ Hybridization Analysis of Philadelphia Chromosome-Negative Chronic Myeloid Leukemia with the bcr/abl Fusion Gene (2004) (8)
Whole-bladder irradiation and doxorubicin-containing chemotherapy as successful treatment for a primary mucosa-associated lymphoid tissue lymphoma of the bladder. (2000) (8)
Induction of murine gamma delta T cells cytotoxic for xenogeneic rat cells. (1995) (8)
Establishment of animal models to analyze the kinetics and distribution of human tumor antigen-specific CD8⁺ T cells. (2013) (8)
Antigen-receptor gene-modified T cells for treatment of glioma. (2012) (8)
Stimulation through very late antigen‐4 and ‐5 improves the multifunctionality and memory formation of CD8+ T cells (2014) (8)
Successful treatment of lymphoid follicular proctitis with sulfasalazine suppositories (2000) (7)
Identification of an immunogenic neo-epitope encoded by mouse sarcoma using CXCR3 ligand mRNAs as sensors (2017) (7)
NY‐ESO‐1 protein glycosylated by yeast induces enhanced immune responses (2010) (7)
Pathway analysis of informative genes from microarray data reveals that metabolism and signal transduction genes distinguish different subtypes of lymphomas. (2004) (7)
IL-4 and IL-10 synergistically inhibit survival of human blood monocytes supported by GM-CSF. (2005) (7)
Immunogenetic identification of functional T-cell subsets. (1976) (7)
Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation. (1999) (7)
Molecular analysis of PDGFRα/β genes in core binding factor leukemia with eosinophilia (2006) (7)
Prognostic Impact of Aortic Calcification Index and Ankle-Arm Blood Pressure Indexin Patients under Hemodialysis (2005) (7)
Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers (2018) (7)
Up-regulation of small GTP-binding proteins smg P21A and ras P21S during TPA-induced differentiation of human leukemia cell lines. (1993) (7)
Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury (2014) (7)
A human T lymphotropic virus type I (HTLV‐I) long terminal repeat‐directed antisense c‐myc construct with an Epstein‐Barr virus replicon vector inhibits cell growth in a HTLV‐I‐transformed human T cell line (1993) (7)
Expression of CD29 on lymphoma cells and/or CD36 on microvascular endothels correlates with high serum LDH level in diffuse large B-cell lymphomas (DLBCLs) and is frequent in de novo CD5-positive DLBCLs. (2005) (7)
State-of-the-Art Review : Coagulation Tests and Anti-Phospholipid Antibodies in Patients Positive for Lupus Anticoagulant (2000) (7)
Preferential usage of JH2 in D-J joinings with DQ52 in murine lymphocytes. (1989) (7)
2015 Guidance on cancer immunotherapy development in early‐phase clinical studies (2015) (7)
Signal-transducing adaptor protein-2 promotes generation of functional long-term memory CD8+ T cells by preventing terminal effector differentiation (2017) (6)
Increased plasma levels of tissue factor pathway inhibitor‐activated factor X complex in patients with disseminated intravascular coagulation (2000) (6)
Rat primary T cells expressing HTLV‐I tax gene transduced by a retroviral vector: In vitro and in vivo characterization (1996) (6)
Autoantibodies to c-myc nuclear protein products in autoimmune disease. (1990) (6)
Tumor-specific targeting of T helper type 1 (Th1) cells by anti-CD3 × anti-c-ErbB-2 bispecific antibody (1999) (6)
Monoclonal antibodies reactive to human platelets: analysis of their specificities, detected antigen molecules, and their effects on platelet function. (1987) (6)
[Targeting cancer antigen (MAGE-A4, NY-ESO -1) for immunotherapy]. (2012) (6)
GD2 Ganglioside‐Specific Monoclonal Antibody Reacts with Murine Cytotoxic T Lymphocytes Reactive with FBL‐3N Erythroleukaemia (1994) (6)
Selective inhibition of human T-lymphotropic virus type I-transformed human T-cell growth by a tax-targeted conditionally cytotoxic recombinant retrovirus (1994) (6)
Tumor responses and early onset cytokine release syndrome in synovial sarcoma patients treated with a novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer. (2019) (6)
Purification and partial amino acid sequence of human platelet membrane glycoproteins IIb and IIIa. (1987) (6)
Autologous and allogeneic typing of human leukemia cells: definition of surface antigens restricted to lymphocytic leukemia cells. (1983) (6)
Self-assembled polysaccharide nanogel delivery system for overcoming tumor immune resistance. (2022) (6)
Plasma Levels of Plasminogen Activator Inhibitor-1 (PAI-1) and Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Patients with Disseminated Intravascular Coagulation (DIC). (2002) (6)
Increased Plasma Soluble-adhesion Molecules in Thrombotic Thrombocytopenic Purpura and Disseminated Intravascular Coagulation (1998) (5)
Changes of Hemostatic Molecular Markers After Gynecological Surgery (2000) (5)
In vivo Retrovirus‐mediated Herpes Simplex Virus Thymidine Kinase Gene Therapy Approach for Adult T Cell Leukemia in a Rat Model (1997) (5)
Endosonographic images of low-grade lymphoma of mucosa-associated lymphoid tissue after radiotherapy. (2001) (5)
Immunotherapy with Chimeric Antigen Receptor Targeting Intracellular WT1 Gene Product Complexed with HLA-a*24:02 Molecule (2015) (5)
Production and analysis of HH 10 monoclonal antibodies reactive to immature hematopoietic cells and their use for monitoring acute leukemia cells. (1985) (5)
Semiquantitative immunoblot analysis of nm23‐H1 and ‐H2 isoforms in adenocarcinomas of the lung: Prognostic significance (2000) (5)
Frequent expression of human Thy-1 antigen on pre-B cell acute lymphoblastic leukemia with t(9;22). (1998) (5)
Effective Transfer of Membrane Proteins from Intact Cells to Liposomes and Preparation of Liposomal Vaccines (1990) (5)
A Heparin-coated Circuit Maintains Platelet Aggregability in Response to Shear Stress in an In Vitro Model of Cardiopulmonary Bypass (1998) (5)
A Case of Acute Myeloid Leukemia with t(7;11)(p15;p15) Mimicking Myeloid Crisis of Chronic Myelogenous Leukemia (2002) (5)
Transcription effect of nm23-M2/NDP kinase on c-myc oncogene. (1997) (5)
Prognostic value of MAGEA4 in primary lung cancer depends on subcellular localization and p53 status. (2018) (5)
A phase II study of (2″ R)-4′ -0-tetrahydropyranyladriamycin (THP) in hematological malignancies (2004) (5)
Isolation of an IgH gene circular DNA clone from human bone marrow. (1989) (4)
Nature of focal lesion and location of skin stimulus influence pattern and distribution of somatosensory evoked potentials (SEP): Forensic and clinical uses (1979) (4)
Differential effects of a murine monoclonal antibody reactive with the disialylgalactosyl residue on the growth of melanoma cells and T cell activation. (1996) (4)
Frequent p53 mutations on exons-5 and exon-8 in human primary gastric-cancer. (1993) (4)
[Plasma D-dimer levels in patients with deep vein thrombosis]. (1999) (4)
Tumor-specific antigens. (1980) (4)
Clinical significance of low protein phosphatase-1 activity of blasts in acute myelogenous leukemia with high white cell counts. (2001) (4)
Blocking of cytotoxic T-cell function of MOLF/Ei mice by anti-Ly 35.1 monoclonal antibody. (1989) (4)
Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia. (2000) (4)
Redirected CD4+ T Cells Using WT1-Specific T-Cell Receptor Gene Transfer Can Supply Multifactorial Help to Enhance the Anti-Leukemia Reactivity Mediated by Similarly Redirected CD8+ T Cells Using the Identical Gene Transfer (2011) (4)
Effect of direct infusion of antifungal agent on invasive pulmonary aspergillosis in a patient with acute leukemia (2002) (4)
G-CSF accelerates the cell-cycling of hematopoietic progenitor cells and abrogates the deceleration by TNF alpha. (1996) (4)
A possible change in doubling time of haemopoietic progenitor cells with stem cell development (1996) (4)
Endoscopic resection of coexisting superficial carcinoma and a retention cyst. (2000) (4)
Immunohistochemical and Semiquantitative Immunoblot Analyses of Nm23-H1 and H2 Isoforms in Normal Human Tissues (1998) (4)
Expression pattern of hybrid phenotype in adult acute lymphoblastic leukemia. (2001) (4)
EXPERIMENTAL MODELS AND THE ROLE OF RNA IN IMMUNOTHERAPY OF LEUKEMIA (1973) (4)
A novel affinity-enhanced NY-ESO-1-targeting TCR-redirected T cell transfer exhibited early-onset cytokine release syndrome and subsequent tumour responses in synovial sarcoma patients (2019) (4)
Haunting appearance of bcr/abl fusion gene products in a patient with therapy related leukaemia. (2006) (4)
Soluble protein encoded by CD44 variant exons 8–10 in the serum of patients with colorectal cancer (1997) (3)
Proliferative response of cloned CTL line 10B-5 upon stimulation with soluble clonotypic monoclonal antibody and its blocking by anti-Lyt-2 antibody. (1989) (3)
Anti B and T cell activity of antiserum to spleen cells of athymic (nu/nu) mice: evidence for surface antigenic differences between functionally distinct subclasses of T and B lymphocytes. (1976) (3)
Increased hemostatic molecular markers in patients undergoing anticoagulant therapy. (2000) (3)
Effects of cyclosporin A on refractory B-cell chronic lymphocytic leukemia. (2000) (3)
CD19-Negative Diffuse Large B-Cell Lymphoma Shows High Serum LDH Level and Poor Prognosis. (2005) (3)
A case of T-lineage lymphoblastic lymphoma/leukemia with t(4;11)(q21;p15) that switched to myelomonocytic leukemia at relapse. (1999) (3)
Stage-specific cell-cycling of hematopoietic progenitor cells. (1997) (3)
Adoptive immunotherapy of cancer utilizing genetically engineered lymphocytes (2015) (3)
[Acute myelogenous leukemia (M4) occurring during chronic lymphocytic leukemia]. (1997) (3)
[Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma]. (2005) (3)
Cellular characteristics of acute leukemia cells simultaneously expressing CD13/CD33, CD7 and CD19. (1997) (3)
Monoclonal Antibodies against Japanese Encephalitis Virus Envelope Glycoprotein V3 (E) (1988) (2)
Production of a truncated human c‐myc protein which binds to DNA (1988) (2)
Clinical Implications of CD4+CD25+Foxp3+Regulatory T Cell Frequencies After CHP-MAGE-A4 Cancer Vaccination. (2018) (2)
Distinctive actions of interleukin-13 and interleukin-4 on growth of hematopoietic progenitors. (1999) (2)
Manipulation of human early T lymphopoiesis by coculture on human bone marrow stromal cells: potential utility for adoptive immunotherapy. (2013) (2)
Distinct Characteristics of t(8;21) Acute Myeloid Leukemia with Active KIT Mutation. (2005) (2)
Randomized phase II clinical trial of NY-ESO-1 protein vaccine combined with cholesteryl pullulan (CHP-NY-ESO-1) in resected esophageal cancer patients (2019) (2)
Effect of Accessory Cells on Stimulation of Murine T‐Cell Leukemia with Antibodies to the CD3/T Cell Antigen Receptor Complex (1993) (2)
Myelodysplastic syndrome of del 20q with plasma cell dysplasia. (2011) (2)
Phase I/II clinical trial of NY-ESO-1-specific TCR-engineered T-cell transfer combined with a novel T-cell stimulator CHP:NE1 for patients with refractory soft tissue sarcoma. (2019) (2)
Selective inhibition of human T-lymphotropic virus type I-transformed human T-cell growth by a tax-targeted conditionally cytotoxic recombinant retrovirus. (1994) (2)
Phase 1 Clinical Trial of Adoptive Immunotherapy for Acute Myelogenous Leukemia and Myelodysplastic Syndrome, Using Gene-Modified Autologous Lymphocytes Expressing WT1-Specific T-Cell Receptor (2016) (2)
High establishment efficiency of lymph node stromal cells which spontaneously produce multiple cytokines derived from adult T-cell leukemia/lymphoma patients. (1996) (2)
Co-Administration Of Gene-Modified CD4+ T Cells Targeting HLA Class I-Restricted WT1 Epitope Diversely Enhances The Antitumor Effect Mediated By Redirected T-Cell Based Adoptive Immunotherapy Against Human Leukemia (2013) (2)
Shear stress-induced myosin association with cytoskeleton and phosphorylation in human platelets. (1997) (2)
[Expression of nm23/NDP kinase and cancer metastasis]. (1996) (2)
Up-regulation of nm23/NDP kinase expression in regenerating hepatocytes. (1997) (2)
Successful treatment of lymphoid follicular proctitis with sulfasalazine suppositories. (2000) (2)
Relationship between T cell receptor clonotype and PD‐1 expression of tumor‐infiltrating lymphocytes in colorectal cancer (2019) (2)
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells (2021) (2)
Rapid lethality of hosts by interleukin-12 following H-2 compatible allogeneic bone marrow transplantation: Reminiscence of gut-associated acute graft-versus-host reaction. (2002) (2)
Frequent expression of MDR1 and MDR3 genes in acute myelocytic leukemia cells with t(8;21) (q22;q22). (1997) (2)
Diverse expression of beta 1,4-N-acetylgalactosaminyltransferase gene in the adult mouse brain. (1995) (2)
Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells (2018) (2)
Inhibition of telomerase activity correlates with a decrease in the RNA component of telomerase during differentiation. (1997) (2)
Successful treatment of aplastic anemia with G-CSF and high dose erythropoietin. (1998) (2)
Possible involvement of protein phosphatase type 2A in tumor necrosis factor alpha-induced tissue factor expression in endothelial cells. (1997) (1)
lcw , 25-Dihydroxyvitamin D ,-Induced Upregulation of Calcineurin During Leukemic HL-60 Cell Differentiation (2002) (1)
Gene Expression Profiling of Diffuse Large B-Cell Lymphomas Supervised by CD21 Expression. (2006) (1)
[Human monoclonal antibodies with human-mouse hybridomas]. (1983) (1)
Study on hemostasis abnormality in patients with diabetic and nondiabetic chronic renal failure on maintenance hemodialysis (2001) (1)
[Cancer vaccine immunotherapy]. (2011) (1)
Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression (2014) (1)
Production and characterization of monoclonal antibody against 10S DNA polymerase alpha from calf thymus. (1982) (1)
Cellular and humoral immune responses in patients vaccinated with HER2 protein combined with a novel nanoparticle antigen delivery system of cholesteryl hydrophobized polysacharide(CHP-HER2) (2005) (1)
Micropatterning with different cell types by dielectrophoretic manipulation (2007) (1)
Variable region gene analysis of 2 human monoclonal-antibodies to gd3. (1993) (1)
Surface phenotype of nonadherent peritoneal cells effecting cell-mediated cytotoxicity in vitro for allogeneic and syngeneic murine sarcoma cells. (1976) (1)
Tumor-Specific TCR-Engineered Donor Lymphocyte Infusion Therapy with Reduced GvHD Induction Utilizing Novel Retrovirus Vector Silencing Endogenous TCR Expression (2014) (1)
[The role of CD44 adhesion molecules]. (1995) (1)
HTLV‐1 unrelated adult T‐cell leukemia/lymphoma with unique phenotype and karyotype (2000) (1)
[Immunotherapy of solid tumor: perspectives on vaccine and cell therapy]. (2012) (1)
Consensus Report, 1987 (1987) (1)
[Cancer treatment with gene-modified T cells or DNA vaccine]. (2010) (1)
[Nuclear P53 immunoreactivity associated with poor prognosis of gastric cancer: preliminary report]. (1992) (1)
Expression of smg p21A and ras p21 in epidermal neoplasms (2004) (1)
Elimination of CD4+ T cells may overcome suppression of anti-HER2 immune responses in tumor-bearing hosts. (2003) (1)
Development of INSOL‐tag for proteome‐wide protein handling and its application in protein array analysis (2019) (1)
Autologous typing: a tedious but orthodox approach for defining human tumor antigens with clarity. (2012) (1)
De Novo CD5+ Diffuse Large B-Cell Lymphoma: Result of a Detail Morphologic Evaluation and Long-Term Follow Up of 128 Patients. (2007) (1)
Chimeric antigen receptor T-cell therapy targeting a MAGE A4 peptide and HLA-A*02:01 complex for unresectable advanced or recurrent solid cancer: protocol for a multi-institutional phase 1 clinical trial (2022) (1)
[Gene expression profiling of de novo CD5-positive diffuse large B-cell lymphoma]. (2003) (1)
Alterations of p53 and k-ras genes in human colorectal-cancer with ulcerative-colitis. (1995) (1)
First-in-human phase I clinical trial of NY-ESO-1 protein cancer vaccine with a novel adjuvant MIS416, NOD2 and TLR9 stimulant, for patients with NY-ESO-1 expressing solid tumors. (2018) (1)
193. Efficacy and Safety of Immunotherapy with Chimeric Antigen Receptor Targeting WT1 and HLA-A24:02 pMHC Complex (2016) (1)
Aggressive neoplastic plasma cell growth with MLL gene rearrangement after high-dose therapy with autologous stem cell support for multiple myeloma (2001) (1)
[Successful treatment of invasive pulmonary aspergillosis with G-CSF and M-CSF during long-term bone marrow suppression in hypoplastic leukemia]. (2002) (1)
EBAG9-silencing exerts an immune checkpoint function without aggravating adverse effects. (2022) (1)
Molecular Analysis of PDGFRα/β Genes in Core Binding Factor Leukemia with Eosinophilia. (2005) (1)
Comparison of the Responses of Global Tests of Coagulation with Molecular Markers of Neutrophil, Endothelial, and Hemostatic System Perturbation in the Baboon Model of E. coli Sepsis (2001) (1)
The role of metabolism on regulatory T cell development and its impact in tumor and transplantation immunity (2022) (1)
HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma (2022) (1)
LIPOPROTEIN(A) AND EFFECTIVE RENAL PLASMA FLOW RATE IN OLDER PATIENTS WITH ARTERIOSCLEROTIC DISEASES (1995) (1)
A Simple Technique to Determine Thrombopoiesis in Thrombocytopenic Patients Using Immature Platelet Fraction (IPF). (2004) (1)
T Cells + in CD8 Growth Associated with Apoptosis Induction Peptide Vaccine Induces Enhanced Tumor (2010) (1)
Tumor- and Immune Cell-Derived Exosomes (2014) (1)
Cell surface antigens: invaluable landmarks reflecting the nature of cells. (2012) (1)
CD22 expression in acute myeloid leukemia: close correlation with interleukin-2 receptor α-chain (CD25) expression and poor prognosis (2022) (1)
Immunoscintigraphy of human tumors transplanted in nude mice with radiolabeled anti-ras p21 monoclonal antibodies. (1990) (1)
PD32-05 PHASE I CLINICAL STUDY ON THE COMBINATION THERAPY OF CHP-NY-ESO-1 CANCER VACCINE AND MIS416 FOR THE TREATMENT OF PATIENTS WITH NY-ESO-1 EXPRESSING REFRACTORY UROTHELIAL CANCER OR CASTRATION-RESISTANT PROSTATE CANCER (2016) (1)
Serum immunoglobulin E response as a marker for unfavorable prognosis following cholesteryl pullulan-MAGE A4 vaccination (2018) (1)
Cell Surface Antigens on Human Leucocytes Defined by Murine Monoclonal Antibodies (1984) (1)
Production of monoclonal antibodies reactive with c-myc protein and analysis of the c-myc expression in leukemic cells. (1988) (1)
Preparation of a murine cell line which stably expresses human T lymphotropic virus type I (HTLV-I) env genome products. (1995) (1)
Dendritic cells transfected with a polyepitope DNA construct stimulate an antitumor cytotoxic response in various tumors. (2022) (1)
[Therapeutic effect of ceftizoxime on severe infectious complications in blood disorders. Tohkai Research Group on Infections in Hematopoietic Disorders]. (1984) (0)
[Plasma fibrin monitor level in DIC patients with a hematopoietic malignancy]. (1996) (0)
A Functionally Superior Second-Generation Vector Expressing an Aurora Kinase-A-Specific T-Cell Receptor for Anti-Leukaemia Adoptive Immunotherapy (2016) (0)
Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients (2013) (0)
[Follicular lymphoma, medium-sized cell type and mixed type]. (1998) (0)
isoforms Adult acute myeloid leukemia cells do not express nonfunctional Ikaros (2012) (0)
CTL-based immunotherapy (PP-109) (2010) (0)
Abstract CT212: Adoptive transfer of wild-type TCR gene transduced T lymphocytes targeting MAGE-A4 antigen to patients with refractory esophageal cancer (2014) (0)
WS-093 a Tumor immunity and immunosurveillance 1 (2010) (0)
Human Telomerase Reverse Transcriptase–specific T-Cell Receptor Gene Transfer Redirects T Cells to Display an Effective Antitumor Reactivity Against Adult T-Cell Leukemia (2012) (0)
Differential Enhancement of Graft-Versus-Host (GVH) and Graft-Versus-Leukemia (GVL) Reactions by Interleukin-12 (IL-12) (1999) (0)
Regulatory T cells in anti-tumor immune responses (2003) (0)
GD 2 ganglioside on human T-lymphotropic virus type I-infected T cells : Possible activation of , B-1 , 4N-acetylgalactosaminyltransferase gene by p 4 OtaX ( adult T-cell leukemia / trans-actvatlon / glycosyltransferase ) (2005) (0)
P56. A novel cancer vaccine with nanogel-based antigen transporter and sequence-optimised long peptide antigen (2014) (0)
Purification and Partial Amino Acid Sequence of Human Platelet Membrane Glycoproteins tIb and lila (2005) (0)
Tumor-Specific Donor Lymphocyte Infusion for Tumor Relapse after MHC-Haploidentical Hematopoietic Stem Cell Transplantation (2016) (0)
Attempt to Harvest a Sufficient Number of Mononuclear Cells in an Appropriate Blood Product Volume By Modification of the Default Apheresis Setting (2017) (0)
Symposium on progress in diagnosis using immunochemical and molecular biological techniques in internal medicine. Cancer diagnosis by oncogenes. (1990) (0)
Subpopulations of cytotoxic t cells with different surface phenotypes. Abstr. (1975) (0)
A phase 1 trial of NY‐ESO‐1‐specific TCR‐engineered T‐cell therapy combined with a lymph node‐targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma (2023) (0)
T-cell lymphoma Δ γ Gene expression profiling of peripheral T-cell lymphoma including (2013) (0)
Study of MAGE-A4 specific TCR-like CAR-T lymphocytes in vitro (2022) (0)
Synergistic Interaction between Notch ligand Delta-1 and IL-6/Soluble IL-6 Receptor Fusion Protein in the Generation of BFU-E from Primitive Hematopoietic Progenitors. (2004) (0)
Assessment of Surface Glycan Diversity on Extracellular Vesicles by Lectin Microarray and Glycoengineering Strategies for Drug Delivery Applications (Small Methods 2/2022) (2022) (0)
Concomitant Administration of Gene-Modified T Cells Expressing a Chimeric CD16-CD3ζ Receptor with Mogamulizmab Synergistically Suppresses Adult T Cell Leukemia Cells in Vivo (2014) (0)
Modern T cell technologies for immunotherapy of solid tumors (2023) (0)
Abstract B11: Control of in vivo spatiotemporal dynamics of antigen and adjuvant by a delivery system CHP nanogel markedly improves the immunogenicity and antitumor efficacy of long peptide cancer vaccine. (2013) (0)
[Molecular biology and multifunctional aspects of nm23/NDPK]. (1998) (0)
A clinical trial of combined immunotherapy with MAGE-A4 peptide and cultured T lymphocyte for patients with head and neck squamous cell carcinoma (2011) (0)
Tumor immunity and immunosurveillance, session 2 (WS-093b) Chairpersons: Takashi Nishimura, Jean-Pierre Abastado (2010) (0)
Divergent Roles of Histone Deacetylases in Human Adult Eythropoiesis. (2005) (0)
121 Tetraspanin molecule CD9 as a novel marker of tumor-reactive T cells (2022) (0)
and argatroban during in vitro extracorporeal circulation Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist (2013) (0)
Polyvalent Cancer Vaccine with a Novel Antigen Delivery System, CHP (cholesterol bearing polysaccharides) (2010) (0)
Search for Cancer Antigens ; Monoclonal Antibodies and Oncogenes (1989) (0)
The influence of different donor rat strains on the immune response in a mouse recipient. (1999) (0)
Therapeutically Infused Redirected T Cells Targeting WT1 Successfully Inhibited Leukemia Stem Cells in Vivo (2012) (0)
[Allogeneic bone marrow transplantation in 14 cases of leukemia]. (1982) (0)
Molecular and Phenotypic Analysis of Philadelphia Chromosome-Positive Bilineage Leukemia: Possibility of a Lineage Switch from T-Lymphoid Leukemia Progenitor to Myeloid Cells Via PU.1 Expression. (2005) (0)
IMMU-08. NOVEL NANOPARTICLE-BASED DELIVERY OF H3.3K27M PEPTIDE TO TUMOR-ASSOCIATED MACROPHAGES ENHANCES THE TUMOR HOMING OF H3.3K27M-TCR TRANSDUCED T-CELLS IN HLA-A2/DR1 TRANSGENIC MICE WITH H3.3K27M+ (2021) (0)
Dual Engineering of Human CD8+ T-Cells with WT1-Specific TCR Gene and Chemokine Receptor Gene Transfer Confers Functionally Strengthened Anti-Cancer Reactivity (2010) (0)
P71. Adoptive transfer of TCR gene-transduced lymphocytes targeting MAGE-A4 for refractory esophageal cancer (2014) (0)
Analysis of lymphocyte differentiation antigens with hybridoma monoclonal antibodies. (1981) (0)
Differential Requirement for Cell Division in the Development of Terminally Differentiated Neutrophils and Macrophages from Their Common Progenitors. (2005) (0)
Targeting Aurora Kinase with a Superior T-Cell Receptor Gene-Transfer Vector (2015) (0)
[Diffuse large B-cell lymphoma of the knee occurring 70 years after tuberculous arthritis]. (2004) (0)
Serological and biochemical characterization of surface antigen expressed on human myeloid cells and identification of six distinct antigen systems. (1988) (0)
99 Structural optimization of anti-CEA-GITR-CAR to reduce tonic signaling and improve antigen-specific reactivity (2020) (0)
Irrelevance of the mutated p53 gene product to tumor rejection antigen in 3-methylcholanthrene-induced fibrosarcomas. (1996) (0)
Early tumor regression following severe lung injury after allogeneic stem cell transplantation in a patient with renal cell carcinoma. (2007) (0)
Title Guanine-rich sequences are a dominant feature of exosomalmicroRNAs across the mammalian species and cell types (2018) (0)
Effector mechanism of H-Y and non-H-2 incompatible skin graft rejection in mice. (1989) (0)
Oligoclonal expansion of cd8+ T-lymphocytes in cultured peripheral lymphocytes derived from asymptomatic HTLV-I carriers. (1994) (0)
Immunological and Clinical Responses in Patients with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Multiple Myeloma (MM) and Chronic Lymphocytic Leukemia (CLL) after RHAMM-R3 Peptide Vaccination. (2007) (0)
[Application of hemostatic molecular markers for diagnosis of thrombosis]. (2000) (0)
Cytokine Release Syndrome and Tumor Responses in a First-in-Man Trial of a Novel Affinity-Enhanced TCR-Gene Transduced T Cell Transfer Targeting NY-ESO-1 Antigen (2017) (0)
Forced Expression of CC Chemokine Receptor 2 Enhances Anti-Cancer Reactivity Mediated by T Lymphocytes Beforehand Redirected Toward WT1 Inside the Tumor Microenvironment (2011) (0)
Feasibility of gene-immunotherapy using WT1-specific T-cell receptor gene transfer for infant acute lymphoblastic leukemia with MLL gene rearrangement (2011) (0)
Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy (2022) (0)
Adult acute myeloid leukemia cells do not express nonfunctional Ikaros isoforms. (2002) (0)
Abstract B34: Signal transducing adaptor protein 2 (STAP2) has the crucial role in maintaining the CTL function of memory T cells (2015) (0)
[Production of monoclonal antibodies]. (1987) (0)
[Diffuse small lymphocytic lymphoma]. (1998) (0)
CANCER DEFINED BY AUTOLOGOUS TYPING (1979) (0)
Oncogenesis and antigenic change of cells: Melanoma and adult T-cell leukemia (1991) (0)
[Adoptive immunotherapy for cancer with genetically engineered T cells]. (2010) (0)
Abstract 5325: Inhibition of CD4+CD25+ regulatory T cell suppression to anti-tumor responses by OK-432 (lyophilized Streptococcus pyogenes) (2010) (0)
[OPINION] Problems of cancer vaccine therapy development (2017) (0)
Delta-1 Promotes Soluble IL-6R-Mediated Action of IL-6 on Human Erythropoiesis While Counteracting the Effect of IL-6 on the Generation of Myeloid-Lineage Cells. (2005) (0)
Negative dielectrophoretic manipulation with microparticles for rapid immunosensing (2008) (0)
Kinase group protooncogenes in non-hodgkins-lymphomas and nonmalignant lymphoid-tissues - analysis of their expression by insitu hybridization assays. (1992) (0)
Plasma‐activated factor VII level in patients positive for lupus anticoagulant (1997) (0)
[Progress in the field of hematology in the last 100 years: Immunotherapy]. (2002) (0)
Association of Circulating CD34+ Cell Count with Liver Conditions. (2004) (0)
[Two cases of acute non-lymphoblastic leukemia treated with allogeneic bone marrow transplantation]. (1982) (0)
Brief report Gene expression proﬁling of peripheral T-cell lymphoma including (cid:1)(cid:2) T-cell lymphoma (2009) (0)
Abstract 2441: An innovative treatment modality of antibody therapy against intracellular tumor antigens (2010) (0)
[Current status of cancer management. 4. Possibility for cancer immunotherapy]. (1998) (0)
Isolation of Human nm 23 Genomes and Analysis of Loss of Heterozygosity in Primary Colorectal Carcinomas Using a Specific Genomic Probe 1 (2006) (0)
Phase I study of CHP-HER2 polyvalent cancer vaccine, HER2 protein combined with a novel nanoparticle antigen delivery system of cholesteryl hydrophobized polysaccharides (2005) (0)
Histopathological Study of Alveolar Bone Resorption Induced with Injections of Escherichia coli Endotoxin into Gingiva of T Cell-depleted Mice. (1995) (0)
Heterogeneity of t cells. Different representations of ly alloan- tigens on killer cells and helper cells. (1975) (0)
Abstract 4751: Peptide vaccine induces apoptosis of antigen-specific CD8+T cells (2010) (0)
Abstract 5615: Effects of corticosteroids on tumor immunity induced by anti-CTLA-4 mAb therapy in a mouse model (2010) (0)
Development of Negative Dielectrophoretic Cellular Patterning System for Living Cells (2006) (0)
[Changes of ADAMTS13 activity and endothelial cell markers in TMA cases]. (2004) (0)
Possible Involvement of Histone Acetylation in Differentiation of Erythroid Precursors and Proliferation of Granulocytic Precursors. (2004) (0)
[Development of immunotherapy against HER2/neu: hydrophobized polysaccharides/oncoprotein complexes and human dendritic cells]. (1999) (0)
Redirected CD4+ T Cells towards HLA Class I-Restricted WT1 Epitope Successfully Display Multifactorial Helper Function for the Enhancement of Antileukemia Efficacy Mediated by Redirected T-Cell Based Immunocelltherapy. (2012) (0)
Targets for Passive Immunotherapy Intracellular Tumor-Associated Antigens Represent Effective (2012) (0)
19. Leukemia and Lymphoma (1987) (0)
O3-7-4Analysis of biomarkers in a pilot study of pertuzumab, trastuzumab and eribulin for advanced HER2 positive breast cancer (2016) (0)
[Clinical evaluation on SM-4300 for severe infections complicated with hematological disorders--a comparative study with cross-over method]. (1984) (0)
359 Hyaluronic acid nanogel based cancer vaccine, in combination with adoptive T cell therapy totally suppresses ICI resistant-tumors (2022) (0)
[Oncogenes and its products in hematopoietic malignancies]. (1987) (0)
Physicians AbstractsEBMT 2011 (2011) (0)
[Mantle cell lymphoma]. (1998) (0)
Increased Membrane Proteinase 3 Expression on Neutrophils in Patients with Infectious Disease. (2004) (0)
[Immunoassays of cancer markers--production and analysis of monoclonal antibodies reactive with ras oncogene p21]. (1987) (0)
Augmented Expression of WT1-Specific TCR and Inhibition of Mispaired-TCR Formation In TCR-Gene Modified T-Cells Can Concomitantly Be Achieved Using a Novel Retroviral Vector with Silencers for Endogenous TCRs (2010) (0)
Human Telomerase Reverse Transcriptase-Specific T-Cell Receptor Gene Transfer Redirects T-Lymphocytes to Exert Effective Antitumor Reactivity Against Adult T-Cell Leukemia, (2011) (0)
Ebp1 expression is induced by influenza virus infection (2008) (0)
Cancer immunotherapy; integration of T cell biology with nanogel- and vector-technology in translational research (2012) (0)
Development of murine mast cells from primitive hematopoietic progenitor cells supported by cytokines in culture (2000) (0)
Biochemical and immunologic diagnosis of cancer. Leukemia and lymphoma. (1987) (0)
MAGE-A4, NY-ESO-1 and SAGE mRNA expression rates and co-expression relationships in solid tumours (2020) (0)
Functional Polymer-coated Exosomes : Nanogel Hybrid Assembly for Drug Delivery System (2013) (0)
Progress of cancer immunotherapy (CS-1) Chairpersons: Nicholas Restifo, Yutaka Kawakami (2010) (0)
Novel Cellular Immunotherapy Using Allogeneic Vγ9/δ2-T Cells Gene-Modified to Express HTLV-1 P40Tax-Specific TCR for the Treatment of Adult T Cell Leukemia (2019) (0)
An Indispensable Role of GM-CSF in the Differentiation of Human Blood Monocytes toward Langerhans Cells. (2005) (0)
Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells (2023) (0)
Abstract PR02: Antigen delivery targeting tumor-infiltrating macrophages leads to eradication of tumor highly resistant to immune checkpoint inhibitors (2017) (0)
In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer (2013) (0)
Molecular Biology of Enzymes Involved in Ganglioside Biosynthesis (1993) (0)
[Successful treatment of Crow-Fukase syndrome with radiation therapy]. (2002) (0)
A Role for Notch Signaling in the Commitment of Human Blood Monocytes to Langerhans Cells. (2004) (0)
[Plasma levels of soluble fibrin in patients with disseminated intravascular coagulation]. (2001) (0)
Development of Novel Stem Cell Transplantation and Gene-Immunotherapy Using WT1-Specific T-Cell Receptor Gene. (2009) (0)
[Dot hybridization with synthetic oligonucleotide; analysis of point mutation of c-ras genes]. (1990) (0)
[Translational research of cancer vaccine]. (2011) (0)
Effect of in Vivo Administration of Anti-Lyt-2 mAb and Anti-L3T4 mAb on Tumor Rejection (1989) (0)
Genetic engineering of T cells with receptors from NY-ESO-1-specific tumor-recognizing CD4+ T cell as a novel approach for adoptive T cell therapy (2015) (0)
17-1The present state of medical care of cancer patients. 4. Possibility of immunotherapy against cancer. (1998) (0)
Tumor immunity and immunosurveillance, session 1 (WS-093a) Chairpersons: Kazuyoshi Takeda, Bruce Robinson (2010) (0)
Airway Inflammation Regulatory T Cells in Th 2-Type + CD 25 + and Preactivated Allergen-Specific CD 4 Differential Regulatory Function of Resting Kuribayashi and Takuma (2008) (0)
Phenotypic and functional features of in vitro generated TCR-T cells specific for the tumor-associated antigen NY-ESO-1 (2022) (0)
Abstract 2408: Selective delivery of NY-ESO-1 antigen protein by cholesteryl pullulan (CHP) to CD8α+ dendritic cells in the draining lymph node for cross-presentation (2010) (0)
Reprogramming of human post-mitotic neutrophils into macrophages by growth factors Running head: Reprogramming of neutrophils into macrophages (2003) (0)
Biliary Carcinomas Induced in the Hamster (2009) (0)
[Oncogene products as tumor markers]. (1987) (0)
Higher frequency of ras oncogene activation in gastric stump carcinomas due to special conditions in the gastric remnant. (1994) (0)
[Cancer diagnosis by oncogenes]. (1990) (0)
Engineering of Human T-Cells with a Novel Aurora-A Kinase-Specific T-Cell Receptor Gene Transfer Confers Anti-Leukemia Reactivity (2010) (0)
AML with t(8;21) and trisomy 4: Possible involvment of c-kit? (multiple letters) [8] (2003) (0)
Phenotype and effector functions of GD2-specific CAR-T lymphocytes in vitro (2022) (0)
A stomach oncofetal antigen recognized by monoclonal antibody GC302 (1987) (0)
growth factors Reprogramming of human post-mitotic neutrophils into macrophages by (2013) (0)
SS9-4 Thioredoxin suppresses airway inflammation independently of systemic Th1/Th2 immune modulation (2010) (0)
Development and Function of Exosomes as Bio–nanotransporters (2015) (0)
Specific Active Immunization Against Cell Surface Antigens of Human Malignant Melanoma: Development of an Approach (1981) (0)
GVHR Basic and Clinical Aspects (1986) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hiroshi Shiku?

Hiroshi Shiku is affiliated with the following schools:

Hiroshi Shiku's Academic­Influence.com Rankings

Hiroshi Shiku's Degrees

Why Is Hiroshi Shiku Influential?

Hiroshi Shiku's Published Works

Published Works

What Schools Are Affiliated With Hiroshi Shiku?

Hiroshi Shiku's AcademicInfluence.com Rankings